Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease

被引:136
作者
Dongiovanni, P. [1 ]
Valenti, L. [1 ]
Rametta, R. [1 ]
Daly, A. K.
Nobili, V. [2 ]
Mozzi, E. [1 ]
Leathart, J. B. S.
Pietrobattista, A. [2 ]
Burt, A. D.
Maggioni, M. [3 ]
Fracanzani, A. L. [1 ]
Lattuada, E. [1 ]
Zappa, M. A. [1 ]
Roviaro, G. [1 ]
Marchesini, G. [4 ]
Day, C. P.
Fargion, S. [1 ]
机构
[1] Univ Milan, Policlin MaRE IRCCS Hosp, I-20122 Milan, Italy
[2] Bambino Gesu Childrens Hosp & Res Ctr, Liver Unit, Rome, Italy
[3] Policlin IRCCS Milan, Milan, Italy
[4] Univ Alma Mater, Bologna, Italy
关键词
ENPP1 K121Q POLYMORPHISM; HEPATIC STEATOSIS; SUBSTRATE-1; GENE; PC-1; RESISTANCE; PREVALENCE; OBESITY; RISK; STEATOHEPATITIS; METABOLISM;
D O I
10.1136/gut.2009.190801
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 ( plasma cell antigen-1) and IRS-1 ( insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7% and 18.1% of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and >2, which was higher in subjects also positive for the 972Arg IRS-1 polymorphism. At multivariate analysis, the presence of the ENPP1 121Gln and IRS-1 972Arg polymorphisms was independently associated with fibrosis >1 ( OR 1.55, 95% CI 1.24 to 1.97; and OR 1.57, 95% CI 1.12 to 2.23, respectively). Both polymorphisms were associated with a marked reduction of similar to 70% of AKT activation status, reflecting insulin resistance and disease severity, in obese patients with NAFLD. Conclusions The ENPP1 121Gln and IRS-1 972Arg polymorphisms affecting insulin receptor activity predispose to liver damage and decrease hepatic insulin signalling in patients with NAFLD. Defective insulin signalling may play a causal role in the progression of liver damage in NAFLD.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 34 条
[1]   FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[3]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[4]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[5]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[6]   From fat to inflammation [J].
Day, CP .
GASTROENTEROLOGY, 2006, 130 (01) :207-210
[7]   Genetics of alcoholic liver disease and nonalcoholic fatty liver disease [J].
de Alwis, Nimantha Mark Wilfred ;
Day, Christopher Paul .
SEMINARS IN LIVER DISEASE, 2007, 27 (01) :44-54
[8]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[9]   Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes [J].
Fracanzani, Anna Ludovica ;
Valenti, Luca ;
Bugianesi, Elisabetta ;
Andreoletti, Marco ;
Colli, Agostino ;
Vanni, Ester ;
Bertelli, Cristina ;
Fatta, Erika ;
Bignamini, Daniela ;
Marchesini, Giulio ;
Fargion, Silvia .
HEPATOLOGY, 2008, 48 (03) :792-798
[10]   The role of membrane glycoprotein plasma cell antigen 1 ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities [J].
Goldfine, Ira D. ;
Maddux, Betty A. ;
Youngren, Jack F. ;
Reaven, Gerald ;
Accili, Domenico ;
Trischitta, Vincenzo ;
Vigneri, Riccardo ;
Frittitta, Lucia .
ENDOCRINE REVIEWS, 2008, 29 (01) :62-75